Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Contraction of collagen gels seeded with tendon cells
Chen, M.-Y., Jeng, Lily, Sun, Y.-L., Zhao, C.-F., Zobitz, M. E., Moran, Steven L. , Amadio, Peter C. , An, K.-N.

Biorheology: The Official Journal of the International Society of Biorheology | November 21, 2024 | Volume: 43 | Issue: 3-4 | Pages: 337-345

10.1177/0006355x2006043003004017 Get It

Knowledge of the adaptation of the soft tissue to mechanical factors and biomolecules would be essential to better understand the mechanism of tendon injury and to improve the outcome of tendon repair. The responses to these factors could be different for the distinct types of cells in the tendon: cells from the tendon sheath, fibroblasts from the epitenon surface, or fibroblasts from the internal endotenon. In this study, we examined the mechanical and histological characteristics of the rate of contraction of the collagen gel seeded with epitenon and endotenon fibroblasts. The rate of contraction and the mechanical property of the contracted construct depend on the gel concentration and also the treatment of TGF-β 1 .
Cardiorespiratory Fitness From Cardiopulmonary Exercise Testing Is a Comprehensive Risk-stratifying Tool in Liver Transplant Candidates
Hughes, Dempsey L. , Wheatley, Courtney M. , Vargas, Hugo E. , Bloomer, Pamela M., Wolf, Cody, Carey, Elizabeth J. , Duarte‐Rojo, Andrés , Duarte-Rojo, Andres , Vargas, Hugo E , Lizaola‐Mayo, Blanca , Forman, Daniel E.

Transplantation Direct | November 21, 2024 | Volume: 10 | Issue: 12 | Pages: e1725

10.1097/txd.0000000000001725 | PMID 39563725 Get It

Background. Cardiovascular disease and physical decline are prevalent and associated with morbidity/mortality in liver transplant (LT) patients. Cardiopulmonary exercise testing (CPX) provides comprehensive cardiopulmonary and exercise response assessments. We investigated cardiorespiratory fitness (CRF) and cardiac stress generated during CPX in LT candidates. Methods. LT candidates at 2 centers underwent CPX. Standard-of-care cardiac stress testing (dobutamine stress echocardiography, DSE) results were recorded. Physical function was assessed with liver frailty index and 6-min walk test. CPX/DSE double products were calculated to quantify cardiac stress. To better study the association of CPX-derived metrics with physical function, the cohort was divided into 2 groups based on 6-min walk test median (372 m). Results. Fifty-four participants (62 ± 8 y; 65% men, Model for End-Stage Liver Disease-Na 14 [10–18]) underwent CPX. Peak oxygen consumption was 14.1 mL/kg/min for an anerobic threshold of 10.2 mL/kg/min, with further CRF decline in the lower 6MWT cohort despite lack of liver frailty index-frailty in 90%. DSE was nondiagnostic in 18% versus 4% of CPX (P = 0.058). All CPX were negative for ischemia. A double product of ≥25 000 was observed in 32% of CPX and 11% of DSE (P = 0.020). Respiratory function testing was normal. No patient presented major cardiovascular events at 30 d post-LT. Conclusions. CPX provided efficient and effective combined cardiopulmonary risk and frailty assessments of LT candidates in a 1-stop test. The CRF was found to be very low despite preserved physical function or lack of frailty.
Clinical utility of pharmacogenomic testing for patients with coccidioidal meningitis
Elkurdi, Rawan, Grill, Marie , Kekić, Adrijana, Blair, Janis E. , Kurdi, Rana , Grill, Marie F, El Kurdi, Rawan , Elkurdi, Rawan

Medical Mycology | November 21, 2024 | Volume: 62 | Issue: 12 | Pages: No page available

10.1093/mmy/myae113 | PMID 39567855 Get It

Abstract Coccidioidomycosis can cause severe meningitis, requiring lifelong treatment. In this study, we sought to better understand the potential effect of pharmacogenomic testing on treatment outcomes of patients with coccidioidal meningitis. Of 13 patients with coccidioidal meningitis who underwent pharmacogenomic testing, 11 had genetic variants of CYP2C19 and CYP3A5 that affect antifungal efficacy. These results led to real-time treatment changes and future antifungal planning. Routine pharmacogenomic testing helps to avoid antifungal treatments that are futile or lead to adverse effects.
Utility of the 2019 EULAR/ACR SLE classification criteria for predicting mortality and hospitalisation: development and cross-validation of ominosity score
Figueroa‐Parra, Gabriel , Hanson, Andrew C. , Sánchez-Rodríguez, Alain , Meade‐Aguilar, José A. , Cuéllar‐Gutiérrez, María C. , Duarte‐García, Alí , Crowson, Cynthia S. , González-Treviño, Mariana, Cuéllar-Gutiérrez, María C, Duarte-García, Alí , Crowson, CS , Figueroa-Parra, Gabriel , Meade-Aguilar, Jose Antonio , González‐Treviño, Mariana , Barbour, Kamil E

RMD Open | November 21, 2024 | Volume: 10 | Issue: 4 | Pages: e004833

10.1136/rmdopen-2024-004833 | PMID 39572074 Get It

Objective The 2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria score (≥20 points) has been associated with poor outcomes. We aimed to evaluate its utility as a predictor for mortality and hospitalisation and to derive and validate an ominosity score based on the SLE classification criteria set. Methods Incident patients with SLE in a population-based cohort were included. The association between the 2019 EULAR/ACR SLE score and mortality and hospitalisation was assessed using Cox regression adjusted for age, sex and calendar year. An ominosity score for mortality was developed based on the SLE criteria set. The least absolute shrinkage and selection operator method was used to estimate model coefficients. Concordance and calibration were assessed by cross-validation and by plotting the observed event rates against the deciles of predicted probabilities. Results Among 374 patients with incident SLE, a EULAR/ACR score ≥20 points was not associated with an increased risk of mortality (HR 1.17, 95% CI 0.67 to 2.03) or first hospitalisation (HR 1.14, 95% CI 0.79 to 1.64) compared with a score ≤19 points. The derived ominosity score for mortality included age, sex, thrombocytopaenia, neuropsychiatric manifestations, subacute cutaneous or discoid lupus, non-scarring alopecia, inflammatory arthritis, renal involvement, antiphospholipid antibodies and hypocomplementaemia. This model demonstrated a concordance=0.76 with adequate calibration. Age and sex were the main predictors, as seen in the model including just age, sex and year (concordance=0.77). Conclusion The 2019 EULAR/ACR SLE criteria score was not associated with mortality and hospitalisation. The derived ominosity score for mortality presented good prediction for mortality but was not better than age and sex alone.
Radiology-pathology correlation: Rosai–Dorfman disease
Benson, John C. , Pais, Alex B, Mark, Ian T. , Chen, John J. , Meyer, Frederic B., Giannini, Caterina, Tobin, William O, Benson, John , Mark, Ian , Chen, John J , Pais, Alex B, Tobin, W. Oliver , Hunt, Christopher H.

The Neuroradiology Journal | November 20, 2024 | Volume: 38 | Issue: 3 | Pages: 299-303

10.1177/19714009241303077 | PMID 39567877 Get It

Rosai–Dorfman Disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a rare non-Langerhans cell histiocytic neoplasm. Although the disease classically presents as massive painless lymphadenopathy in young adults, RDD can also involve the central nervous system in some patients. CNS lesions, can cause headaches, neurologic deficits, and even neurologic deficits. The imaging appearance of CNS RDD typically mimics that of meningiomas: well-circumscribed dural-based lesions that often have dural tails. However, some imaging clues also exist that might help a radiologist recognize RDD, even before histopathologic confirmation. This radiology-pathology report of a patient with CNS RDD highlights the most pertinent clinical, imaging, and pathologic features of CNS RDD, and discusses what the neuroradiologist needs to know about the disease.
Assessment of In-Office Tympanostomy Tube Insertion Tolerability in Children Under 2 Years
Cofer, Shelagh A. , Badaoui, Joseph N. , Rimell, Franklin L. , Nimmons, Grace L., Raisen, Jay , Tombers, Nicole M. , Truitt, Theodore O. , Rimell, Frank , Tombers, Nicole

Ear, Nose & Throat Journal | November 20, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/01455613241300890 | PMID 39567866 Get It

Objective: In-office tympanostomy tube insertion (TTI) is becoming more available in the practice of pediatric otolaryngology. This study evaluated the tolerability of this procedure in young children. Method: Four methods were used to assess tolerability. (1) Standardized video recordings were collected from 30 patients under 24 months who underwent in-office TTI with a single-pass insertion device with topical anesthesia alone. The videos were then reviewed by 3 independent experts in pediatric care and rated at 5 procedural time points using a defined response scale developed with the U.S. Food and Drug Administration. (2) Separately, overall tolerability was subjectively assessed by the same experts. (3) Patient recovery was assessed by the participating otolaryngologist and support staff. (4) Patient caregivers were surveyed for their impressions of the procedure, including whether they would recommend it to other caregivers. Results: In a total of 90 reviews, 100% of children were successfully treated and were rated as having acceptably tolerated the in-office tympanostomy tube procedure. All patients returned to an acceptable baseline without inappropriate crying and were assessed as fully recovered immediately following the procedure or by the time the child was leaving clinic. For caregivers, 93% agreed or strongly agreed that they would recommend the use of in-office TTI to other caregivers. Conclusions: In-office TTI in young children was determined to be universally well tolerated in young children and is a procedure that patient caregivers would recommend to other caregivers for their children. These results should help reassure otolaryngology specialists and caregivers alike that in-office ear tube placement is a viable option for young children with middle ear disease.
Diagnostic Complexity in Monoclonal Gammopathy of Thrombotic Significance
Kanack, Adam J. , Leung, Nelson , Padmanabhan, Anand , Leung, Nelson , Padmanabhan, Anand

New England Journal of Medicine | November 20, 2024 | Volume: 391 | Issue: 20 | Pages: 1961-1963

10.1056/nejmc2409428 | PMID 39565997 Get It

American College of Surgeons Operative Standards and Breast Cancer Outcomes
Taylor, Crystal D., Wang, Ton , Baskin, Alison S. , Sinco, Brandy, Boffa, Daniel J., Dossett, Lesly A. , Hughes, Tasha M. , Boughey, Judy C.

JAMA Network Open | November 20, 2024 | Volume: 7 | Issue: 11 | Pages: e2446345

10.1001/jamanetworkopen.2024.46345 | PMID 39565622 Get It

ImportanceThe American College of Surgeons (ACS) operative standards were established to detail critical elements of cancer surgery, reduce technical variation, and improve outcomes. Two of the 6 operative standards target adequate axillary surgery for breast cancer. The potential association of the operative standards with short-term oncologic outcomes, such as nodal yield and nodal positivity rates, is currently unknown.ObjectiveTo evaluate the potential association of the ACS operative standards with short-term oncologic outcomes in breast cancer.Design, Setting, and ParticipantsA cohort study was performed using data on 1 201 317 women 18 years or older who underwent sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) for invasive breast cancer from January 1, 2012, to December 31, 2020. Patients were identified using the National Cancer Database (NCDB), a clinical oncology database encompassing approximately 70% of new cancer diagnoses, sourced from hospital registry data from 1317 facilities. Statistical analysis was performed from October 2023 to June 2024.ExposureSentinel lymph node biopsy or ALND.Main Outcomes and MeasuresReliability-adjusted facility-level lymph node yield and nodal positivity rate for each procedure were calculated using generalized linear mixed models, Poisson regression, and logistic regression with facility-level random intercepts.ResultsThe cohort included 1 201 317 women with a median age of 62 years (IQR, 53-70 years). Facility-level nodal yield ranged from 1 to 6 for SLNB and from 6 to 22 for ALND. Median facility-level nodal yield for SLNB was 2.6 (IQR, 2.3-3.0) and the nodal positivity rate for SLNB was 12.2% (IQR, 11.0%-13.7%), with rates ranging from 6% to 21%. A weak correlation between facility-level lymph node yield and nodal positivity was observed (Spearman correlation coefficient, 0.17). Median nodal upstaging rate (≥4 positive nodes) for ALND was 30.5% (IQR, 26.5%-35.0%), with rates ranging from 11% to 54%; median nodal yield was 12.2 (IQR, 10.9-13.6). A strong correlation between nodal yield and nodal upstaging rates was observed (Spearman correlation coefficient, 0.53).Conclusions and RelevanceIn this cohort study of women undergoing axillary surgery for invasive breast cancer, facility-level variation in lymph node yield was present for both SLNB and ALND, which could potentially be improved through the ACS operative standards. However, this variation had mixed associations with nodal positivity and upstaging rates, suggesting the association of the ACS operative standards with oncologic outcomes may be mixed.
Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights
Khurshid, Humera , Ismaila, Nofisat , Das, Millie , Manochakian, Rami , Weinberg, Frank , Kalemkerian, Gregory P. , Manochakian, Rami , Weinberg, Frank , Kalemkerian, Gregory P , Das, Millie , Kulkarni, Swati

JCO Oncology Practice | November 20, 2024 | Volume: 21 | Issue: 6 | Pages: 754-758

10.1200/op-24-00840 | PMID 39565981 Get It

Pre-declaration Fetal Dose Assignment and Predictive Full term Fetal Dose at Medical Facilities
Underwood, James Kyle, Sturchio, Glenn M.

Health Physics | November 20, 2024 | Volume: 128 | Issue: 5 | Pages: 423-427

10.1097/hp.0000000000001914 | PMID 39565235 Get It

Abstract Many medical facilities across the United States use ionizing-radiation-producing machines and radioactive materials for diagnostic and therapeutic purposes on a regular basis. While institutions are required to ensure full-term fetal doses are below the regulatory limit, clear guidance on how pre-declaration fetal doses should be estimated is not available. This paper provides a process that can be used to estimate the pre-declaration fetal dose and provides a predictive screening tool for licensees to use to recommend workload adjustments prior to actual fetal dosimetry results that could exceed the institutions derived investigation levels. The evaluation process presented herein serves as a guide for medical licensees when performing fetal dose evaluations for declared pregnant workers.